ChiaClaramae Profile Banner
Claramae Chia Profile
Claramae Chia

@ChiaClaramae

Followers
163
Following
417
Media
35
Statuses
169

Busy either chasing cancer or my kids!

Singapore
Joined June 2015
Don't wanna be here? Send us removal request.
@Deeplamichhane3
Deep lamichhane
6 months
We have started PIPAC services at Bhaktapur Cancer Hospital. Nepal's first PIPAC carried out today. 18 months of PSM program (23 CRS+HIPEC) Lot to learn. Today, I want to honor, remember and express my gratitude to all the mentors.
1
3
23
@rand_spa
RanD Spa
6 months
The annual "Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course" at the @nccsingapore has just finished and it was a success! Thank you @ChiaClaramae for the amazing organization and see you all next year! @PSOGI_EC @ISSPP1 #HIPEC
0
2
11
@ChiaClaramae
Claramae Chia
6 months
0
0
1
@ChiaClaramae
Claramae Chia
6 months
1
0
3
@ChiaClaramae
Claramae Chia
6 months
Kicking off our Hipec/Pipac workshop! @ISSPP1 @PSOGI_EC thank you @somusp9 Ignace Clarisse faheez Martin!
1
0
7
@somusp9
Somashekhar SP
6 months
Always pleasure to visit Singapore πŸ‡ΈπŸ‡¬ Singapore – Where Science Meets Skyline Welcome to Singapore β€” a dynamic city-state where cutting-edge medicine blends seamlessly with world-class culture, innovation, and beauty. A global medical hub renowned for its precision, planning,
1
2
16
@somusp9
Somashekhar SP
6 months
Singapore compressive course and workshop on Peritoneal malignancy HIPEC and PIPAC started with bang πŸ’₯: Participants from 16 different countries πŸ€—πŸ‘ŒπŸ‘ŒπŸ‘πŸ‘πŸ‘πŸ‘@ChiaClaramae @ISSPP1 @PSOGI_EC @IspsmHipec
2
1
11
@oncodaily
OncoDaily
6 months
0
1
13
@rand_spa
RanD Spa
6 months
RAND Spa is happy to attend the "Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course", taking place at the National Cancer Centre Singapore on April 14-16, under the direction of Prof. @ChiaClaramae , and endorsed by @PSOGI_EC #HIPEC
0
3
13
@ChiaClaramae
Claramae Chia
7 months
Beautiful mahabalipuram!
1
0
2
@alarjosan
Alvaro Arjona
7 months
PIPAC is an effective treatment to control the peritoneal malignant diseases in gastric, colon, ovarian and meshotelioma. We have introduced this technique for selected patients @HUReinaSofia @HcrCordoba @ISSPP1 @ChiaClaramae @operarelcancer @GrupoTTD
1
13
47
@oncodaily
OncoDaily
7 months
New podcast alert: Palliative surgery of peritoneal malignancies – Peritoneal Surface Oncology Group International (PSOGI) @ChiaClaramae @Jolenewongsm https://t.co/5QJO6hkR0e #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
0
2
15
@PSOGI_EC
Peritoneal Surface Oncology Group International
7 months
πŸ“’ New podcast alert #ResearchSpotlight Palliative surgery of peritoneal malignancies 🎧🎧🎧🎧🎧🎧🎧🎧🎧🎧🎧 https://t.co/Gj4jjKUGUJ 🎧🎧🎧🎧🎧🎧🎧🎧🎧🎧🎧 Palliative surgery is crucial in the management of peritoneal malignancies as it directly impacts the patients quality of
0
6
17
@NewsJellybelly
News (PMP) Pseudomyxoma Peritonei Appendix Cancer
1 year
0
5
15
@PSOGI_EC
Peritoneal Surface Oncology Group International
1 year
A great event hosted at a great venue ! The #14th international congress PSOGI/ISSPP came to a close on Saturday with a whopping 594 participants representing all 6 continents, 86 speakers and 19 exhibitors #LYON2024 #PSOGIISSPP2024 -For the 1⃣πŸ₯‡ time, the @PSOGI_EC , the
2
11
26
@alarjosan
Alvaro Arjona
1 year
Great controversy session today focus on HIPEC for colorectal cancer in Lousanne meeting @MartinHbner3 @ISSPP1 @DeliaCortesGuir @oliviawriting @nfmkok @somusp9 @ChiaClaramae
3
5
28
@ChiaClaramae
Claramae Chia
1 year
Happening now in LYon? Who’s going to win the fight? @DeliaCortesGuir @alarjosan ShigekiKusamura @PSOGI_EC @ISSPP1
1
3
9
@glehenolivier
glen
1 year
Happy to share exciting expertise in Lyon with high level expertise and to present the first international consensus on peritonectomy procedures with gynecologists colleagues and friends
0
8
19
@ChiaClaramae
Claramae Chia
1 year
https://t.co/ehAAjs7Gow Row with Us: Support Team SPRinT and help patients with Rare & Advanced Cancers
0
1
4